SAIPARENT Share Price | Sai Parenterals Ltd Stock Analysis & Recommendation

Q: Why is Sai Parenterals Ltd falling/rising?

As of 17-Aug, the stock price of Sai Parenterals Ltd is falling, currently at 550.40, which reflects a decrease of 1.5 (-0.27%). The stock has been on a downward trend, having lost value for the last two consecutive days, resulting in a total decline of -2.58% during this period. Additionally, the stock touched an intraday low of Rs 537.4, marking a decrease of -2.63%. In terms of performance relative to the benchmark, the stock has underperformed over the past week, with a decline of -6.28% compared to the Sensex's -1.04%. Over the past month, it has also seen a slight decrease of -1.15%, while the Sensex fell by only -0.54%. The falling investor participation is another contributing factor, as the delivery volume on 14 August dropped by -53.05% compared to the 5-day average, indicating reduced interest from investors. Although the stock is currently trading above its 100-day and 200-day moving averages, it is below its 5-day, 20-day, and 50-day moving averages, suggesting a short-term weakness in price momentum. Overall, these factors collectively indicate a bearish trend for Sai Parenterals Ltd.

Q: What does Sai Parenteral's do?

Overview: Sai Parenterals Ltd operates in the Pharmaceuticals & Biotechnology industry and is categorized as a Small Cap company.History: Sai Parenterals Ltd was originally incorporated as 'Sai Parenteral's Private Limited' on January 12, 2001. The company later converted to a Public Limited Company, changing its name to 'Sai Parenteral's Limited' on January 17, 2022. The most recent quarterly results reported net sales and net profit for June 2026.Financial Snapshot: Most recent Net Sales: 179 Cr (Quarterly Results - Jun 2026) Most recent Net Profit: 8 Cr (Quarterly Results - Jun 2026) Market-cap value: INR 2,434 Cr (Small Cap)Key Metrics: P/E: 157.00 Industry P/E: 37 Dividend Yield: 0.00% Debt-Equity: -0.17 Return on Equity: 2.91% Price to Book: 4.95 Contact Details: Details: No Company Details Available Registrar Address: Not available.

Q: Who are the peers of the Sai Parenteral's?

Peers: The peers of Sai Parenteral's are Dishman Carbogen, Hikal, Ind-Swift Labs., Solara Active, Panacea Biotec, Fredun Pharma, Venus Remedies, NGL Fine Chem, Hester Bios, and Beta Drugs Ltd.Quality Snapshot: Excellent management risk is observed at Fredun Pharma and Venus Remedies, while Average management risk is found at Hikal, Fredun Pharma, Venus Remedies, NGL Fine Chem, Hester Bios, and Beta Drugs Ltd, and the rest. Below Average management risk is present at Dishman Carbogen, Ind-Swift Labs., Solara Active, Panacea Biotec. In terms of Growth, Excellent growth is seen at Fredun Pharma, Good growth is noted at Dishman Carbogen and Venus Remedies, while Average growth is found at Beta Drugs Ltd, and Below Average growth is observed at Hikal, Ind-Swift Labs., Solara Active, Panacea Biotec, Hester Bios, and the rest. Capital Structure ratings show Excellent at Venus Remedies and NGL Fine Chem, Average at Ind-Swift Labs. and Beta Drugs Ltd, and Below Average at Dishman Carbogen, Hikal, Solara Active, Panacea Biotec, Fredun Pharma, Hester Bios.Return Snapshot: The peer with the highest 1-year return is Fredun Pharma at 330.64%, while the peer with the lowest is Dishman Carbogen at -22.16%. Sai Parenteral's 1-year return is not available for comparison. Additionally, Beta Drugs Ltd has a six-month return of 0.00%, indicating no growth in that period.

Q: How big is Sai Parenteral's?

As of 14th August, Market Cap: Sai Parenterals Ltd has a market capitalization of 2,497.00 Cr, categorizing it as a Small Cap company.Recent Quarterly Performance: The sum of Net Sales for the latest 4 quarters is 506.14 Cr, while the sum of Net Profit for the same period is 15.84 Cr.Balance Sheet Snapshot: The reporting period for the balance sheet is March 2025. Shareholder's Funds are valued at 93.67 Cr, and Total Assets amount to 271.86 Cr.

Technical Trend Update: Sai Parenteral's witnessed a change in Technical Grade on 17 Aug 2026. Click here to discover latest technical change!

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

63.22 k (-63.43%) Volume

Shareholding (Jun 2026)

FII

4.03%

Held by 7 FIIs

DII

8.52%

Held by 3 DIIs

Promoter

51.16%

Why is Sai Parenterals Ltd falling/rising?

18-Aug-2026

As of 17-Aug, the stock price of Sai Parenterals Ltd is currently at 550.40, reflecting a downward trend with a total decline of -2.58% over the last two days. The stock has underperformed compared to the Sensex and shows signs of short-term weakness in price momentum.

View full answer

Which are the latest news on Sai Parenteral's?

18-Aug-2026

When is the next results date for Sai Parenterals Ltd?
When is the next results date for Sai Parenterals Ltd?

What does Sai Parenteral's do?

14-Aug-2026

Sai Parenterals Ltd is a small-cap company in the Pharmaceuticals & Biotechnology industry, incorporated in 2001 and converted to a public company in 2022. As of June 2026, it reported net sales of ₹179 Cr and a net profit of ₹8 Cr, with a market cap of ₹2,434 Cr.

View full answer

Who are the peers of the Sai Parenteral's?

14-Aug-2026

Sai Parenteral's peers include Dishman Carbogen, Hikal, Ind-Swift Labs, Solara Active, Panacea Biotec, Fredun Pharma, Venus Remedies, NGL Fine Chem, Hester Bios, and Beta Drugs Ltd. Fredun Pharma leads in 1-year return at 330.64%, while Dishman Carbogen has the lowest at -22.16%.

View full answer

How big is Sai Parenteral's?

14-Aug-2026

As of 14th August, Sai Parenterals Ltd has a market capitalization of 2,497.00 Cr, with recent net sales of 506.14 Cr and a net profit of 15.84 Cr over the last four quarters.

View full answer

When is the next results date for Sai Parenterals Ltd?

05-Aug-2026

The next results date for Sai Parenterals Ltd is 11 August 2026.

View full answer

Compare Sai Parenteral's with Similar Stocks

Solara Active Panacea Biotec Fredun Pharma

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

Unrated Stock - No Analysis Available

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

INR 2,419 Cr (Small Cap)

P/E

151.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

-0.17

Return on Equity

2.91%

Price to Book

4.95

Revenue and Profits:

Net Sales:

179 Cr

(Quarterly Results - Jun 2026)

Net Profit:

8 Cr

Total Returns

Total Returns (Price + Dividend)

Dividend Yield (0%)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

13.0%

6 Months

0.0%

1 Year

0.0%

2 Years

0.0%

3 Years

0.0%

4 Years

0.0%

5 Years

0.0%

Sai Parenteral's for the last several years.

Risk Adjusted Returns v/s

Returns Beta

Beta has not been calculated since enough price history is not available

News & Corporate Actions

News

When is the next results date for Sai Parenterals Ltd?

The next results date for Sai Parenterals Ltd is scheduled for 11 August 2026....

Read full news article

When is the next results date for Sai Parenterals Ltd?

Sai Parenterals Ltd is scheduled to declare its results on 23 May 2026....

Read full news article

Announcements

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

12-Aug-2026 | Source : BSE

Audio Recording of the Earnings call held on 12th August 2026

Announcement under Regulation 30 (LODR)-Investor Presentation

12-Aug-2026 | Source : BSE

Investor Presentation Q1 FY 2027

Statement On Deviation Or Variation Of Funds Under Regulation 32 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.

11-Aug-2026 | Source : BSE

Statement on deviation or varition of funds

Corporate Actions

BOARD MEETING

No Upcoming Board Meetings

DIVIDEND

No Dividend history available

SPLITS

No Splits history available

BONUS

No Bonus history available

RIGHTS

No Rights history available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

EBIT Growth (5y)

EBIT to Interest (avg)

1.93

Debt to EBITDA (avg)

8.61

Net Debt to Equity (avg)

Sales to Capital Employed (avg)

0.46

Tax Ratio

Tax Ratio is Negative%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

12.56%

ROCE (avg)

5.37%

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

151

Industry P/E

Price to Book Value

4.87

EV to EBIT

105.66

EV to EBITDA

59.66

EV to Capital Employed

5.67

EV to Sales

6.06

PEG Ratio

Dividend Yield

ROCE (Latest)

5.37%

ROE (Latest)

2.91%

Technicals key factors

Indicator

Weekly

Monthly

MACD

RSI

No Signal

Bollinger Bands

Sideways

KST

Dow Theory

No Trend

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Jun 2026

Shareholding Compare (%holding)

Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 1 Schemes (0.98%)

FIIs

Held by 7 FIIs (4.03%)

Promoter with highest holding

Vijitha Gorrepati (28.91%)

Highest Public shareholder

Bhaskara Rao Bollineni (4.56%)

Individual Investors Holdings

25.33%

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Jun'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2026 is -7.06% vs 47.58% in Mar 2026",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2026 is -10.75% vs 2,663.89% in Mar 2026",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'26",
        "Mar'26",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "52.78",
          "val2": "56.79",
          "chgp": "-7.06%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "13.35",
          "val2": "13.22",
          "chgp": "0.98%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "3.57",
          "val2": "3.42",
          "chgp": "4.39%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "8.88",
          "val2": "9.95",
          "chgp": "-10.75%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "25.29%",
          "val2": "23.28%",
          "chgp": "2.01%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "86.92",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "16.17",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Interest",
          "val1": "4.63",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "7.77",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "18.60%",
          "val2": "NA%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Jun'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Jun'26",
        "",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "265.59",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "39.69",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Interest",
          "val1": "13.99",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "15.69",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "14.94%",
          "val2": "NA%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2026 is 133.58% vs 6.08% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2026 is -1.18% vs 71.38% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "381.00",
          "val2": "163.11",
          "chgp": "133.58%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "38.70",
          "val2": "39.38",
          "chgp": "-1.73%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "18.44",
          "val2": "11.91",
          "chgp": "54.83%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "14.26",
          "val2": "14.43",
          "chgp": "-1.18%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "10.16%",
          "val2": "24.14%",
          "chgp": "-13.98%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Standalone) - Jun'26 - QoQ

Jun'26

Mar'26

Change(%)

Net Sales

52.78

56.79

-7.06%

Operating Profit (PBDIT) excl Other Income

13.35

13.22

0.98%

Interest

3.57

3.42

4.39%

Exceptional Items

0.00

Standalone Net Profit

8.88

9.95

-10.75%

Operating Profit Margin (Excl OI)

25.29%

23.28%

2.01%

Values in Rs Cr.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Jun 2026 is -7.06% vs 47.58% in Mar 2026

Standalone Net Profit

QoQ Growth in quarter ended Jun 2026 is -10.75% vs 2,663.89% in Mar 2026

All Quarterly Results

Half Yearly Results Snapshot (Consolidated) - Sep'25

Sep'25

Change(%)

Net Sales

86.92

Operating Profit (PBDIT) excl Other Income

16.17

Interest

4.63

Exceptional Items

0.00

Consolidate Net Profit

7.77

Operating Profit Margin (Excl OI)

18.60%

NA%

Values in Rs Cr.

Compare with Peers

Net Sales

Not Applicable: The company has declared_date for only one period

Consolidated Net Profit

Not Applicable: The company has declared_date for only one period

All Half Yearly Results

Nine Monthly Results Snapshot (Consolidated) - Jun'26

Jun'26

Change(%)

Net Sales

265.59

Operating Profit (PBDIT) excl Other Income

39.69

Interest

13.99

Exceptional Items

0.00

Consolidate Net Profit

15.69

Operating Profit Margin (Excl OI)

14.94%

NA%

Values in Rs Cr.

Compare with Peers

Net Sales

Not Applicable: The company has declared_date for only one period

Consolidated Net Profit

Not Applicable: The company has declared_date for only one period

All Nine Monthly Results

Annual Results Snapshot (Consolidated) - Mar'26

Mar'26

Mar'25

Change(%)

Net Sales

381.00

163.11

133.58%

Operating Profit (PBDIT) excl Other Income

38.70

39.38

-1.73%

Interest

18.44

11.91

54.83%

Exceptional Items

0.00

Consolidate Net Profit

14.26

14.43

-1.18%

Operating Profit Margin (Excl OI)

10.16%

24.14%

-13.98%

Values in Rs Cr.

Compare with Peers

Net Sales

YoY Growth in year ended Mar 2026 is 133.58% vs 6.08% in Mar 2025

Consolidated Net Profit

YoY Growth in year ended Mar 2026 is -1.18% vs 71.38% in Mar 2025

All Annual Results

Company CV

About Sai Parenterals Ltd

Sai Parenterals Ltd

Small Cap

Pharmaceuticals & Biotechnology

Sai Parenteral's Limited was originally incorporated as `Sai Parenteral's Private Limited', a Private Limited Company on January 12, 2001, with the Registrar of Companies, at Hyderabad. Thereafter, Company was converted into a Public Limited Company and the name of Company was changed to `Sai Parenteral's Limited' w.e.f January 17, 2022.

Company Coordinates

No Company Details Available